Article Listing - FDA expands Bayer/Janssen's Xarelto use to treat, reduce recurrence of blood clots

1991 A BAD YEAR FOR SOLVAY

20 April 1992

Consolidated net profits at the Belgian chemicals company Solvay fell 22% in 1991 to 12.4 billion Belgian francs ($367.6 million)...

CIBA-GEIGY SPAIN PROFITS DOWN

20 April 1992

Net profits at the Spanish subsidiary of the Swiss chemical and pharmaceutical company Ciba-Geigy fell 43% in 1991 to around...

USA: MINNESOTA HEALTHRIGHT PLAN

20 April 1992

Last week, the state of Minnesota was expected to adopt its massive and controversial HealthRight plan, making it the first...

US FDA USER FEE REG THIS MONTH?

20 April 1992

User fee legislation is currently being drafted by the US Food and Drug Administration and could be ready for submission...

TRIAL COULD BOOST VIDEX ACCEPTANCE

20 April 1992

Results of a clinical study involving Bristol-Myers Squibb's antiviral Videx (didanosine) as a treatment for patients with AIDS suggest that...

ICI HONORED FOR DIPRIVAN ADVANCE

20 April 1992

The UK's ICI Pharmaceuticals has been granted the 1992 Queen's Award for Technological Achieve-ment for the development of the injectable...

ICI AMERICAS IN DELAWARE

20 April 1992

The pharmaceutical group of ICI Americas is investing $24.7 million in an expansion project at its Newark, Delaware site. Construction...

FIRST QTR RESULTS FROM DEPRENYL

20 April 1992

Canadian pharmaceutical company Deprenyl Research Ltd achieved revenues of C$2.8 million ($2.3 million) in the first quarter of 1992, an...

CURATEK FILES NDA FOR METROGEL-V

20 April 1992

Illinois, USA-based Curatek Pharma-ceuticals has submitted a New Drug Application to the Food and Drug Administration for a topical formulation...

US PATENT GRANTED FOR INHIBIN

20 April 1992

A US patent has been awarded to Biotech Australia with Monash University, Prince Henry's Institute of Medical Research and St...

Showing 94261-94270 of 95365 articles

Go to beginningPreviousNextGo to end